Mayo Clinic, Arizona
13400 East Shae Boulevard
Scottsdale, Arizona 85259
Amy Duffy (480) 301-4750
Shayamal Menta, MD, PhD
Charles Adler, MD, PhD
Dr. Adler’s research can be divided into three main categories. He is first involved in leading the effort to clinically characterize a cohort of subjects enrolled in a brain donation program. This program involves annual clinical evaluation for movement disorders and cognitive function. It is performed at multiple institutions in the Phoenix area, including Mayo Clinic and Sun Health Research Institute. All subjects then donate their brains at the time of death. The research led by Dr. Adler includes investigating early signs (clinical biomarkers) for the development of Parkinson’s disease and dementia in Parkinson’s disease. Additionally, Dr. Adler collaborates with Dr. Thomas Beach, the neuropathologist at Sun Health Research Institute, as well as multiple laboratory-based scientists investigating the potential etiology for Parkinson’s disease, dementia in Parkinson’s disease, essential tremor, and restless legs syndrome. A second main feature of Dr. Adler’s research program is the investigation of normal and abnormal movement in various disorders. This includes studying handwriting and other movements in patients with Parkinson’s disease, as well as muscle movement in golfers with and without golfer’s cramp (yips). The third area of research is Dr. Adler’s investigations of new treatments for multiple movement disorders. This includes pharmaceutical trials as well as new treatments being studied by the NIH and single-site studies performed only at Mayo Clinic.
John N. Caviness, MD
The clinical practice of John N. Caviness, M.D., involves movement disorders, electrophysiology of movement disorders and interpretation of electroencephalography. His main research interest is cortical function in Parkinson’s disease and its role in cognitive deterioration and dementia.
Erika D. Driver-Dunckley, MD
Dr. Driver-Dunckley is currently involved in research studies on Parkinson’s disease, dystonia, restless leg syndrome and brain wellness.
These studies involve epigenetics and the pathology of Parkinson’s disease with the Arizona Parkinson’s Disease Consortium (APDC) and the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND).
Additionally, she is involved in drug studies for Parkinson’s disease, dystonia, and restless leg syndrome.